Holen Sie sich die Stockscreener-App
1.53
3.16%
-0.05
Handel nachbörslich:
1.53
Schlusskurs vom Vortag:
$1.58
Offen:
$1.58
24-Stunden-Volumen:
60,061
Relative Volume:
0.19
Marktkapitalisierung:
$65.62M
Einnahmen:
$51.13M
Nettoeinkommen (Verlust:
$-93.80M
KGV:
-0.6861
EPS:
-2.23
Netto-Cashflow:
$-129.10M
1W Leistung:
-1.29%
1M Leistung:
+10.07%
6M Leistung:
+33.04%
1J Leistung:
-61.65%
1-Tages-Spanne:
$1.51
$1.5904
1-Wochen-Bereich:
$1.51
$1.62
52-Wochen-Spanne:
$0.89
$4.0974
Repare Therapeutics Inc Stock (RPTX) Company Profile
Firmenname
Repare Therapeutics Inc
Sektor
Branche
Telefon
(857) 412-7018
Adresse
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Vergleichen Sie RPTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
1.53 | 66.91M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-09 | Hochstufung | Stifel | Hold → Buy |
| 2023-02-03 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-06 | Eingeleitet | CapitalOne | Overweight |
| 2022-04-12 | Herabstufung | Stifel | Buy → Hold |
| 2022-03-17 | Fortgesetzt | Goldman | Buy |
| 2021-09-23 | Eingeleitet | Stifel | Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-06-28 | Eingeleitet | Guggenheim | Buy |
| 2021-03-01 | Eingeleitet | Berenberg | Buy |
| 2020-10-28 | Eingeleitet | Northland Capital | Outperform |
| 2020-07-14 | Eingeleitet | Cowen | Outperform |
| 2020-07-14 | Eingeleitet | Goldman | Neutral |
| 2020-07-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-14 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Repare Therapeutics Inc Aktie (RPTX) Neueste Nachrichten
Can Repare Therapeutics Inc. hit a new high this monthFree Momentum Based Equity Trading Plan - Newser
Will Repare Therapeutics Inc. benefit from macro trendsTrade Ideas Based on Fundamental Metrics - Newser
Repare Therapeutics (NASDAQ:RPTX) Shares Up 0.6%Should You Buy? - MarketBeat
Is Repare Therapeutics Inc. Stock a Good Fit for Conservative InvestorsEquity Forecast with Predictive AI Screener - Newser
Quantitative breakdown of Repare Therapeutics Inc. recent moveWeekly Breakout Forecast with Entry Zones - Newser
Real Time Chart Alerts Flash Bullish on Repare Therapeutics Inc.AI Driven Stock Trend Forecast Shows Momentum Shift - metal.it
Ichimoku Cloud Indicates Uncertainty Around Repare Therapeutics Inc.Market Surge Signal for Swing Traders Triggered - metal.it
How many analysts rate Repare Therapeutics Inc. as a “Buy”Market-beating returns - jammulinksnews.com
Pattern recognition hints at Repare Therapeutics Inc. upsideFree News Based Entry Opportunity Alerts - Newser
Best data tools to analyze Repare Therapeutics Inc. stockValue Investing Summary and Earnings Outlook - Newser
How high can Repare Therapeutics Inc. stock go Strong Buy Signal Summary with Entry Zone - Newser
How does Repare Therapeutics Inc. compare to its industry peersCapitalize on market trends with confidence - jammulinksnews.com
What are the technical indicators suggesting about Repare Therapeutics Inc.Consistently high yield - jammulinksnews.com
What are Repare Therapeutics Inc. company’s key revenue driversInvest smarter with comprehensive market analysis - jammulinksnews.com
How strong is Repare Therapeutics Inc. company’s balance sheetDiscover dynamic stocks ready to soar - jammulinksnews.com
ARK Investment Management LLC Sells 875,514 Shares of Repare Therapeutics Inc. (NASDAQ:RPTX) - MarketBeat
How Repare Therapeutics Inc. stock performs during market volatilityLow Risk Trading Ideas - Newser
Repare Therapeutics (NASDAQ:RPTX) Trading 0.6% Higher – What’s Next? - Defense World
Is Repare Therapeutics Inc. a good long term investmentMassive portfolio appreciation - PrintWeekIndia
Will Repare Therapeutics Inc. stock benefit from interest rate changesExplosive earnings growth - jammulinksnews.com
Why Repare Therapeutics Inc. stock is on top investor watchlistsUnrivaled growth potential - jammulinksnews.com
What analysts say about Repare Therapeutics Inc. stock outlookMarket-leading growth rates - jammulinksnews.com
What drives Repare Therapeutics Inc. stock priceFree Wealth Planning Blueprint - Autocar Professional
What analysts say about Repare Therapeutics Inc. stockPowerful growth strategies - jammulinksnews.com
Why Repare Therapeutics Inc. stock attracts strong analyst attentionFree Access to Community - Newser
Repare Therapeutics Inc. Stock Analysis and ForecastUnprecedented growth rates - jammulinksnews.com
what makes repare therapeutics inc. stock price move sharplyLow Risk Profit Ideas - Newser
Finanzdaten der Repare Therapeutics Inc-Aktie (RPTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Repare Therapeutics Inc-Aktie (RPTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER |
Mar 12 '25 |
Sale |
1.14 |
5,611 |
6,397 |
80,297 |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER |
Mar 12 '25 |
Sale |
1.14 |
6,884 |
7,848 |
54,786 |
| Segal Lloyd Mitchell | PRESIDENT AND CEO |
Mar 12 '25 |
Sale |
1.14 |
21,179 |
24,144 |
124,394 |
10.28%
2.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):